$FTRE

Morais Mark A. sold $75K of FTRE

Morais Mark A. (Chief Operating Officer) sold 4,866 shares of Fortrea Holdings Inc. (FTRE) at $15.49 on 2026-06-02.

Original reporting
SEC EDGAR · Morais Mark A.
Published Jun 3, 2026, 8:08 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 3, 2026, 8:23 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$FTRE
Neutral
medium confidence
Mentioned
$FTRE
Relevance
6/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$FTRENeutralLow
01

Why it matters

The market may briefly scrutinize the sale, but there is no accompanying guidance, deal, or regulatory development in the article.

02

Market read

Primarily a sentiment/positioning datapoint for FTRE; likely low incremental impact absent other catalysts.

03

What to watch

Insider sales often reflect diversification, tax planning, or scheduled personal events; without context on prior sales and total insider activity, directional inference is weak.

Relevance 6/10Novelty 6/10Timing: Filed 2026-06-03; sale executed 2026-06-02 (after market close timing depends on filing dissemination).

Background

This is an SEC Form 4 insider transaction disclosure (officer/direct holdings change), not an earnings or corporate action update.

Company-level read

Ticker impact

$FTRENeutralMedium confidence
Context

Fortrea COO Mark Morais sold 4,866 shares in an open-market transaction on 2026-06-02, disclosed via SEC Form 4.

Expected impact

Likely limited near-term impact; any reaction should be small unless accompanied by other company-specific news.

Evidence & confidence

The filing provides a dated insider sale and price, but no new company fundamentals, contracts, or outlook changes.

Market effects

Minimal—single insider transaction typically does not reset sector expectations.

None indicated.

None indicated.

Counterpoint

The absence of a stated 10b5-1 plan could be misread as bearish; the sale size may still be routine liquidity/compensation-related.

Key entities

  • Fortrea Holdings Inc.

    Subject of the insider transaction disclosure; COO sold shares via open-market sale.

  • Morais Mark A.

    Chief Operating Officer who sold 4,866 shares at $15.49/share.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$FTREMed

Fortrea Holdings Inc: Fortrea to Acquire Clinical Pharmacology Unit and Bioanalytical Laboratory Operations from Worldwide Clinical Trials

Fortrea (FTRE) will acquire Worldwide Clinical Trials' Early Phase Services division for $45M, including a bioanalytical lab and clinical pharmacology unit. The deal expands Fortrea's early clinical development capabilities, enhancing its platform for Phases I-IV studies. Worldwide will focus on its late-stage business. The transaction is subject to regulatory approvals.

$FTREHighAI 9/10

Fortrea Q2 Earnings Call Highlights

"The environment has become more supportive, but our results are not simply the result of market recovery," Thakral said, attributing the performance to changes in commercial execution, including improved global coordination, a sharper focus on opportunities where the company can compete effectively and a clearer approach to serving distinct customer segments. Thakral said Fortrea's clinical pharmacology services business was a particular area of strength.

$FTREMedAI 8/10

Fortrea (NASDAQ:FTRE) Reports Strong Q2 CY2026, Full

Fortrea Holdings (NASDAQ:FTRE) reported Q2 CY2026 revenue of $678.2 million, down 4.5% year over year but 4.7% above market expectations, according to the company. Full-year revenue guidance was $2.66 billion at the midpoint, 1.8% above analysts’ estimates. Non-GAAP EPS was $0.23, 27.2% above consensus.

$FTREMed

Fortrea Holdings Inc. (FTRE): Results of Operations and Financial Condition

Fortrea Holdings Inc. (FTRE) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Fortrea Reports Second Quarter 2026 Results Four consecutive quarters of execution to drive commercial, operational and financial excellence Increases full-year guidance Highlights For the three months ended June 30, 2026: • Revenues of $678.2 million • Book-to-bill